# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-023225
Filing Date
2025-03-13
Accepted
2025-03-13 07:32:22
Documents
4
Period of Report
2025-03-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | tm2426563d2_6k.htm | 6-K | 12518
2 | EXHIBIT 99.1 | tm2426563d2_ex99-1.htm | EX-99.1 | 120147
3 | EXHIBIT 99.2 | tm2426563d2_ex99-2.pdf | EX-99.2 | 4018675
4 | GRAPHIC | tm2426563d2_ex99-1img001.jpg | GRAPHIC | 6791
| Complete submission text file | 0001104659-25-023225.txt |  | 5657409

Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 25733841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)